Back
Grupo Gigante SAB de CV Vs. PTC Therapeutics Industry Stock Comparison
Buy
62
GPGNF
Grupo Gigante SAB de CV
Last Price:
1.57
Seasonality Move:
9.04%
Sell
48
PTCT
PTC Therapeutics
Last Price:
34.68
Seasonality Move:
8.27%
Buy
62
Grupo Gigante SAB de CV (GPGNF)
is a Buy
Is Grupo Gigante SAB de CV a Buy, Sell or Hold?
- The current Grupo Gigante SAB de CV [GPGNF] share price is $1.57. The Score for GPGNF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- GPGNF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $34.66. The Score for PTCT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPGNF Stock Price Chart
What is Grupo Gigante SAB de CV's stock price today?
-
The Grupo Gigante SAB de CV share price today is $1.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPGNF is experiencing slight buying pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $34.66
The current trend is moderately bearish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
GPGNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 30.14 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.56 - 1.62) | Sell |
Bollinger Bands (100): | (1.56 - 1.68) | Sell |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 46.91 | Sell |
Chaikin Money Flow: | -549814 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.18 - 37.66) | Sell |
Bollinger Bands (100): | (26.54 - 35.16) | Buy |
GPGNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.57 | Sell |
20-day SMA: | 1.59 | Sell |
50-day SMA: | 1.61 | Sell |
200-day SMA: | 1.49 | Buy |
8-day EMA: | 1.57 | Sell |
20-day EMA: | 1.58 | Sell |
50-day EMA: | 1.6 | Sell |
200-day EMA: | 1.52 | Buy |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.17 | Sell |
20-day SMA: | 36.3 | Sell |
50-day SMA: | 33.67 | Buy |
200-day SMA: | 27.7 | Buy |
8-day EMA: | 35.34 | Sell |
20-day EMA: | 35.63 | Sell |
50-day EMA: | 34.08 | Buy |
200-day EMA: | 31.84 | Buy |
Grupo Gigante SAB de CV Earnings Growth & GPGNF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.10 per share, an increase this year of $0.53 per share, and an increase next year of $2.08 per share.
Grupo Gigante SAB de CV Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |